ποΈ Verified NIH Record β’ Updated 2025-08-18
Destination Therapy Post Approval Study (NCT03681210)
π΅ Active, Not Recruiting Interventional Protocol π Observational Clinical Research Sponsor: Medtronic Cardiac Rhythm and Heart Failure
π©Ί Plain-English Summary (8th-Grade Level)
Medtronic is sponsoring the HeartWareβ’ HVADβ’ Destination Therapy (DT) Post Approval Study (PAS) to further confirm safety and effectiveness of the HeartWare Ventricular Assist Device System (HVAD System) when used as intended, in "real-world" clinical practice. The Destination Therapy Post Approval Study (DT PAS) is conducted within Medtronic's Product Surveillance Platform.
Who can join: Review the eligibility criteria below.
Location: Saint Vincent Heart Clinic Arkansas β Little Rock, Arkansas
Age range: 18 Years
π§ͺ Interventions in This Study
π "Do I Qualify?" β 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria β
π All Participating Trial Locations (47 Sites)
Showing the first 25 of 47 sites.
- Saint Vincent Heart Clinic Arkansas β Little Rock, Arkansas
- University of California San Diego β San Diego, California
- University of California San Francisco Medical Center β San Francisco, California
- Stanford University Hospital β Stanford, California
- University of Colorado β Aurora, Colorado
- University of Miami β Coral Gables, Florida
- Mayo Clinic (Jacksonville FL) β Jacksonville, Florida
- AdventHealth β Orlando, Florida
- University of South Florida Health β Tampa, Florida
- Northwestern University β Chicago, Illinois
- Loyola University β Maywood, Illinois
- Advocate Christ Medical Center (Cardiac Surgery Clinical Research Center) β Oak Lawn, Illinois
- Saint Vincent Medical Group β Indianapolis, Indiana
- The University of Kansas Medical Center β Kansas City, Kansas
- University of Louisville Hospital β Louisville, Kentucky
- University of Maryland Medical Center β Baltimore, Maryland
- The Johns Hopkins Hospital β Baltimore, Maryland
- Tufts Medical Center β Boston, Massachusetts
- Massachusetts General Hospital β Boston, Massachusetts
- Henry Ford Health System β Detroit, Michigan
- University of Minnesota β Minneapolis, Minnesota
- Mayo Clinic Rochester β Rochester, Minnesota
- Washington University School of Medicine β St Louis, Missouri
- University of Nebraska Medical Center β Omaha, Nebraska
- NYU Langone Medical Center β New York, New York
π° Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA Β§ 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Chronic Heart Failure
- R&D Study to Evaluate Cordio's Usability and to Collect Patient Speech Utterances β South Windsor, Connecticut
- Patient SELF-management With HemodynamIc Monitoring: Virtual Heart Failure Clinic and Outcomes β Montreal, Quebec
- Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System β La Jolla, California
- Comparing the Effects of Combining Cognitive and Physical Exercise Training on Cognition, and Cerebral Blood Flow Regulation in Men and Women With Chronic Heart Failure β Montreal, Quebec
- Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure β Pasadena, California
Explore by condition: All Chronic Heart Failure clinical trials
π‘ How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.